Our Location
304 North Cardinal St.
Dorchester Center, MA 02124
Ibrutinib (Ibruxen) is used to treat blood cancer like lymphocytic leukemia (CLL), mantle cell lymphoma (MCL), Waldenström macroglobulinemia (WM), and marginal zone lymphoma (MZL).
Multiple-myeloma, also known as myeloma, is a form of blood cancer that affects plasma cells in the bone marrow.